U.S. FDA Authorizes Eli Lilly's COVID-19 Antibody Drug
- Aryaman Sinha
- Feb 14, 2022
- 1 min read
The U.S. Food and Drug Administration on Friday authorized Eli Lilly and Co's COVID-19 antibody drug for people aged 12 and older at risk of severe illness, adding a tool that has been found to work against the highly contagious Omicron variant. Awesome!
Photo Credit: Franck
Comments